Outcomes in skilled nursing facilities versus other locations in outpatient parenteral antimicrobial therapy among patients with substance use disorders
Armani M. Hawes(School of the Art Institute of Chicago), Sara C. Keller(Johns Hopkins University), Oluwaseun Falade‐Nwulia(Johns Hopkins University), Megan Buresh(Johns Hopkins University), Lisa R. Yanek(Johns Hopkins University), Rawan Abdel-Galil(Johns Hopkins University), Alia Bodnar(Johns Hopkins University)
Cited by 0
Related Papers
Hepatitis C Guidance 2018 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection
|Clinical Infectious Diseases|2018|728
Oral Direct-Acting Agent Therapy for Hepatitis C Virus Infection
|Annals of Internal Medicine|2017|694
Meta-Analysis of Genome-Wide Association Studies in African Americans Provides Insights into the Genetic Architecture of Type 2 Diabetes
|PLoS Genetics|2014|246
Cerebral small vessel disease genomics and its implications across the lifespan
|Nature Communications|2020|210